Selskabets formål er at drive virksomhed med klinikdrift, teknologioverførsel, licensering, produktion, handel samt hermed beslægtet virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | -1.5 mio. | -4.7 mio. | 12.6 mio. | 3.2 mio. | 1 | |
CVR: 28655010
Secondary names: PROKAREX A/S, PROFERMIN A/S, IBD KLINIKKEN A/S
Previous names: IBD KLINIKKEN A/S, NORDISK REBALANCE A/S
Compared to 994 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Companies in the same industry and area
CVR 29973687
CVR 42368660
CVR 28951329
CVR 46218620
CVR 27145876
Mats Stefan Persson left the board
Morten Duch joined the board
Ola Martin Olsson joined the board
Martin Olsson left the board
Jan Peter Fredrik Wennström joined the board
Sven Ingvar Wirfelt joined the board
Niels Christian Westergård-Nielsen left the board
companydata.dk